Literature DB >> 499314

Long-term hemodynamic effects of penbutolol at rest and during exercise in essential hypertension.

P Lund-Johansen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 499314     DOI： 10.1007/bf00562054

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  13 in total

1.  Haemodynamic response to graded exercise during chronic beta-adrenergic blockade with bunitrolol, an agent with intrinsic sympathomimetic activity.

Authors:  T Reybrouck; A Amery; R Fagard; L Billiet
Journal:  Eur J Clin Pharmacol       Date:  1977-12-16       Impact factor: 2.953

2.  Long-term hemodynamic effects of bunitrolol at rest and during exercise in essential hypertension.

Authors:  P Lund-Johansen
Journal:  J Cardiovasc Pharmacol       Date:  1979 Jan-Feb       Impact factor: 3.105

3.  Hemodynamic long-term effects of timolol at rest and during exercise in essential hypertension.

Authors:  P Lund-Johansen
Journal:  Acta Med Scand       Date:  1976

4.  Long term treatment of moderate hypertension with penbutolol (Hoe 893d). I. Effects on blood pressure, pulse rate, catecholamines in blood and urine, plasma renin activity and urinary aldosterone under basal conditions and following exercise.

Authors:  B G Hansson; B Hökfelt
Journal:  Eur J Clin Pharmacol       Date:  1975-10-10       Impact factor: 2.953

5.  Hemodynamic changes at rest and during exercise in long-term beta-blocker therapy of essential hypertension.

Authors:  P Lund-Johansen
Journal:  Acta Med Scand       Date:  1974 Jan-Feb

6.  Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations.

Authors:  R C Tarazi; H P Dustan
Journal:  Am J Cardiol       Date:  1972-05       Impact factor: 2.778

7.  Haemodynamic long-term effects of metoprolol at rest and during exercise in essential hypertension.

Authors:  P Lund-Johansen; O J Ohm
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

8.  Penbutolol in hypertension: a pilot study with single daily doses.

Authors:  V H Yajnik; J S Nandi; S C Patel; H V Doshi; S H Patel
Journal:  J Int Med Res       Date:  1977       Impact factor: 1.671

9.  Haemodynamic long-term effects of a new beta-adrenoceptor blocking drug, atenolol (ICI 66082), in essential hypertension.

Authors:  P Lund-Johansen
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

10.  Haemodynamic effects of pindolol in hypertensive patients.

Authors:  J H Atterhög; H Dunér; B Pernow
Journal:  Acta Med Scand Suppl       Date:  1977
View more
  3 in total

1.  How intrinsic sympathomimetic activity modulates the haemodynamic responses to beta-adrenoceptor antagonists. A clue to the nature of their antihypertensive mechanism.

Authors:  A J Man in 't Veld; M A Schalekamp
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

2.  Penbutolol (Hoe 893d) in primary hypertension. Blood pressure effects, tolerance and plasma concentrations.

Authors:  K P Ohman; J Asplund; S Landahl; B Liander
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

3.  Penbutolol: a preliminary review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-07       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.